Immediate implant with bovine drived hydroxyapatite xenograft.immediate implant with zinc incorporated bovine drived hydroxyapatite xenograft
Immediate implant with bovine drived hydroxyapatite xenograft.: patients will undergo immediate implant with bovine drived hydroxyapatite xenograft.
immediate implant with zinc incorporated bovine drived hydroxyapatite xenograft: patients will undergo immediate implant with zinc incorporated bovine drived hydroxyapatite xenograft
Study summary
The aim of this study is to evaluate Clinical and radiographic effect of zinc incorporated bovine derived hydroxyapatite xenograft and bovine hydroxyapatite xenograft alone for immediately placed implant
Eligibility
Sex
ALL
Min age
21 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Adult(male or female) patients between the ages of 21 -50 years who requiring the replacement of one or more non-restorable teeth in the mandible which will be indicated for extraction.
* Adequate bone dimensions at the implant site with ridge width of at least 6 mm, the availability of at least 3mm of sound subapical bone, the presence of an intact labial bone plate, and no evidance of periapical infection on cone beam computed tomography or clinically
* The peri-implant gaps larger than 1.5 mm will be included.
* All patients will be physically healthy with no medical history of any systemic disease.
Exclusion Criteria:
* Smokers.
* Patients with para functional habits such as bruxism and clenching
* Poorly controlled systemic diseases which preclude local anesthesia or surgical procedures
* Patients undergoing chemotherapy or radiotherapy and immuno-compromised patients.
* Pregnant /lactating women.
* Patients that are allergic to zinc
* Patients on antibiotic therapy in the pervious 6 months
Primary outcome measure(s)
Marginal bone loss — 9 months Marginal bone loss was defined as the distance from the implant platform to the alveolar crest.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.